Gender Dysphoria Prescribing and Monitoring Local Enhanced Service

The contracting process for the "Gender Dysphoria Prescribing and Monitoring Local Enhanced Service" was conducted by the NHS Nottingham and Nottinghamshire Integrated Care Board. This procurement falls under the health services category and focuses on prescribing hormone treatments for transgender patients who experience gender dysphoria. The procurement method applied was limited, without prior publication of a call for competition, due to urgent circumstances following the Health Care Services (Provider Selection Regime) Regulations 2023.

The process reached the award stage, finalised on 2 July 2025, and the contract service provision spans from 1 April 2025 to 31 March 2026 in regions UKF14, UKF15, and UKF16. This tender presents significant growth opportunities particularly for healthcare service providers capable of delivering specialised hormone treatments within urgent timeframes. Businesses with existing healthcare infrastructure and the ability to rapidly mobilise resources in Nottinghamshire might find this contract particularly lucrative, especially those that can adequately address immediate risks to safety and quality of care, as the award criteria emphasised.

Given the nature of the procurement and the existing need for swift service delivery, larger organisations with experience in managing enhanced medical services could have a competitive advantage in such contracting processes.